Loading...

Wait a minute

Precision Medicine

Advancing care through clinically validated, diagnostic testing
Overview Why Precision Medicine Diagnostics Matter Our Approach to Precision Medicine Diagnostics Precision Medicine Capabilities at Parkway Laboratories Precision Oncology Genomic Diagnostics Women’s Health & Reproductive Genetics Personalised Risk Stratification A Trusted Diagnostic Partner for Precision Medicine

Overview of Precision Medicine

Precision medicine diagnostics play a critical role in modern clinical practice, enabling more accurate diagnosis, risk stratification, and treatment selection based on the biological characteristics of each patient.

At Parkway Laboratory Services, we are an early adopter of clinically validated diagnostic testing that supports precision medicine across oncology, genomics, and complex disease evaluation. Our integrated laboratory capabilities allow clinicians to access timely, reliable diagnostic insights that inform confident clinical decision-making.

Why Precision Medicine Diagnostics Matter

Many diseases, particularly cancer and genetically influenced conditions, are biologically heterogeneous. Patients with the same clinical diagnosis may respond very differently to treatment.

Precision medicine diagnostics help clinicians to:

  • Identify disease-specific biomarkers and molecular drivers
  • Align patients with the most appropriate targeted or personalised therapies
  • Reduce trial-and-error treatment approaches
  • Support earlier and more confident clinical decisions

As therapeutic strategies become increasingly biomarker-driven, access to accurate and clinically relevant diagnostic information has become essential to patient care.

Our Approach to Precision Medicine Diagnostics

Parkway Laboratories adopts a diagnostics-led approach to precision medicine, focused on clinical relevance, analytical robustness, and integration across laboratory disciplines.

Our approach is defined by:

  • Early adoption of validated diagnostic assays, including companion diagnostics aligned with approved therapies
  • Diagnostic testing capabilities, spanning histopathology, immunohistochemistry, in situ hybridisation, molecular diagnostics, and genomics
  • Integrated laboratory workflows that support efficient and reliable result interpretation
  • Alignment with regulatory and clinical standards, including HSA-approved testing and treatment pathways

We work closely with clinicians and specialists to ensure our diagnostic offerings remain relevant to evolving standards of care.

Precision Medicine Capabilities at Parkway Laboratories

Our precision medicine diagnostics support a wide range of clinical applications, with a strong emphasis on oncology and genomic-driven care.

Precision Oncology

Diagnostic testing to support personalised cancer care, including:

  • Biomarker and companion diagnostic assays
  • Immunohistochemistry and ISH testing
  • Molecular oncology and genomic profiling
  • Integrated diagnostic evaluation to guide treatment selection

[Learn more about Oncology Diagnostics ->]

Genomic Diagnostics

Genetic and molecular testing to support risk assessment, diagnosis, and treatment planning, including:

  • Germline and hereditary risk testing
  • Genomic evaluation for disease predisposition
  • Pharmacogenomic insights to support therapy selection

Women’s Health & Reproductive Genetics

Precision diagnostics supporting women’s health and reproductive care, including:

  • Reproductive and prenatal genetic testing
  • Molecular diagnostics for gynaecological conditions
  • Personalised screening and risk stratification

Personalised Risk Stratification

Diagnostic testing to support early risk identification and preventive care, enabling clinicians to tailor monitoring and management strategies to individual patient profiles.

A Trusted Diagnostic Partner for Precision Medicine

Delivering precision medicine diagnostics requires more than technology. It requires diagnostic expertise, robust governance, and seamless integration with clinical workflows.

Parkway Laboratories provides:

  • Comprehensive in-house laboratory capabilities
  • Experienced pathologists and laboratory specialists
  • Strong quality and governance frameworks
  • Integrated digital and laboratory systems supporting clinical workflows

Through precision medicine diagnostics, we support clinicians in delivering care that is informed, personalised, and aligned with the future of medicine.

Precision medicine diagnostics play a critical role in modern clinical practice, enabling more accurate diagnosis, risk stratification, and treatment selection based on the biological characteristics of each patient.

At Parkway Laboratory Services, we are an early adopter of clinically validated diagnostic testing that supports precision medicine across oncology, genomics, and complex disease evaluation. Our integrated laboratory capabilities allow clinicians to access timely, reliable diagnostic insights that inform confident clinical decision-making.

Many diseases, particularly cancer and genetically influenced conditions, are biologically heterogeneous. Patients with the same clinical diagnosis may respond very differently to treatment.

Precision medicine diagnostics help clinicians to:

  • Identify disease-specific biomarkers and molecular drivers
  • Align patients with the most appropriate targeted or personalised therapies
  • Reduce trial-and-error treatment approaches
  • Support earlier and more confident clinical decisions

As therapeutic strategies become increasingly biomarker-driven, access to accurate and clinically relevant diagnostic information has become essential to patient care.

Parkway Laboratories adopts a diagnostics-led approach to precision medicine, focused on clinical relevance, analytical robustness, and integration across laboratory disciplines.

Our approach is defined by:

  • Early adoption of validated diagnostic assays, including companion diagnostics aligned with approved therapies
  • Diagnostic testing capabilities, spanning histopathology, immunohistochemistry, in situ hybridisation, molecular diagnostics, and genomics
  • Integrated laboratory workflows that support efficient and reliable result interpretation
  • Alignment with regulatory and clinical standards, including HSA-approved testing and treatment pathways

We work closely with clinicians and specialists to ensure our diagnostic offerings remain relevant to evolving standards of care.

Our precision medicine diagnostics support a wide range of clinical applications, with a strong emphasis on oncology and genomic-driven care.

Diagnostic testing to support personalised cancer care, including:

  • Biomarker and companion diagnostic assays
  • Immunohistochemistry and ISH testing
  • Molecular oncology and genomic profiling
  • Integrated diagnostic evaluation to guide treatment selection

Learn more about Oncology Diagnostics →

Genetic and molecular testing to support risk assessment, diagnosis, and treatment planning, including:

  • Germline and hereditary risk testing
  • Genomic evaluation for disease predisposition
  • Pharmacogenomic insights to support therapy selection

Precision diagnostics supporting women's health and reproductive care, including:

  • Reproductive and prenatal genetic testing
  • Molecular diagnostics for gynaecological conditions
  • Personalised screening and risk stratification

Diagnostic testing to support early risk identification and preventive care, enabling clinicians to tailor monitoring and management strategies to individual patient profiles.

Delivering precision medicine diagnostics requires more than technology. It requires diagnostic expertise, robust governance, and seamless integration with clinical workflows.

Parkway Laboratories provides:

  • Comprehensive in-house laboratory capabilities
  • Experienced pathologists and laboratory specialists
  • Strong quality and governance frameworks
  • Integrated digital and laboratory systems supporting clinical workflows

Through precision medicine diagnostics, we support clinicians in delivering care that is informed, personalised, and aligned with the future of medicine.

Chat with us
Chat with us